中国药理学与毒理学杂志2016，Vol.30Issue(4)：375-380,6.DOI:10.3867/j.issn.1000-3002.2016.04.012
非小细胞肺癌生物标志物在个体化治疗方面的研究进展
Progress in biomarkers of non-small cell lung cancer for individualized treatment
刘长姣 1李明春2
作者信息
- 1. 大连医科大学药学院，辽宁大连116000
- 2. 中国人民解放军第401医院药剂科，山东青岛266071
- 折叠
摘要
Abstract
Biomarkers of non-small cell lung cancer(NSCLC)can facilitate an efficient diagnosis, improve therapeutic effects,reduce the side effects of other treatments,ameliorate prognosis and predict relapse of the disease and drug resistance. This paper summarized the biomarkers which were newly discovered and their functions in clinical practices in order to guide individualized treatment and help adjust treatment. The exploration of biomarkers of NSCLC will become a priority in future research.关键词
非小细胞肺癌/生物标志物/表皮生长因子/放化疗Key words
non-small cell lung cancer/biomarkers/epidermal growth factor/chemoradiotherapy分类
医药卫生引用本文复制引用
刘长姣,李明春..非小细胞肺癌生物标志物在个体化治疗方面的研究进展[J].中国药理学与毒理学杂志,2016,30(4):375-380,6.
